#Altamira #Therapeutics #attending #TIDES #Europe
Hamilton, Bermuda, Nov. 10, 2022 (GLOBE NEWSWIRE) — • The TIDES Europe event will take place from November 16th to 18th, 2022 in Vienna, Austria
• Covadonga Pañeda, Ph.D., the Company’s Chief Development Officer, will present the benefits of Altamira’s OligoPhoreTM / SemaPhoreTM RNA delivery technology
• dr Pañeda to discuss the Company’s two proprietary RNA programs, AM-401 and AM-411
Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to the development of therapeutics that address important unmet medical needs, today announced that it will be attending in person the TIDES Europe: Oligonucleotide and Peptide Therapeutics hybrid event, taking place November 16-18, 2022 at the Austria Center in Vienna. Austria. For details see: https://informaconnect.com/tides-europe/
Covadonga Pañeda, Ph.D., Altamira’s Chief Development Officer, will present the following points in her presentation: “Challenges to systemic extrahepatic RNA delivery and endosomal…
Read on GNW: Altamira Therapeutics is attending TIDES Europe
